Restatement of Consolidated Financial Statements (CONSOLIDATED STATEMENTS OF CASH FLOWS) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended		9 Months Ended		12 Months Ended
	Jan. 01, 2022	Jul. 03, 2021	Jan. 02, 2021	Apr. 02, 2022	Apr. 03, 2021	Jul. 02, 2022	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021	Oct. 03, 2020
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income										$ 133,169
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	$ 27,465		$ 27,635	$ 55,032	$ 54,831	$ 82,097	$ 82,204	$ 108,783	$ 109,656	114,218
Stock-based compensation expense	9,032		8,208	18,362	17,432	29,045	26,147	39,608	34,976	26,235
Deferred income taxes	6,059		3,858	9,173	8,787	15,993	26,946	27,910	28,375	11,772
Gain on sale of intellectual property									(15,000)
Gain on liquidation of foreign entity							(8,263)		(8,263)
Impairment of goodwill and other assets						1,848		1,848		8,409
Loss on sale of intellectual property								7,000
Other, net	(3,638)		(99)	(1,903)	(19)	(3,146)	(633)	1,260	(1,371)	(239)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	(106,656)		(66,961)	(79,308)	(79,333)	(40,276)	(108,008)	47,483	(145,810)	81,914
Contract assets	(15,393)		28,680	(67,092)	64,722	(112,606)	53,231	(143,531)	54,479	9,631
Inventories	(213,278)		57,469	(403,783)	90,490	(552,851)	(7,419)	(651,118)	(157,278)	24,377
Prepaid expenses and other assets	(2,939)		(8,694)	(11,334)	2,065	(13,269)	(2,868)	(31,700)	(5,780)	17,092
Accounts payable	240,591		(66,657)	362,191	(99,525)	507,909	61,524	558,828	243,834	(106,640)
Accrued liabilities	70,880		28,814	161,137	6,024	152,192	(54,861)	124,099	(49,022)	(19,383)
Cash provided by operating activities	68,300		61,811	147,273	142,900	248,956	246,621	330,854	338,342	300,555
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:
Purchases of property, plant and equipment								(138,639)	(73,296)	(65,982)
Proceeds from sales of property, plant and equipment								8,425	1,084	1,573
Purchases of investments								(2,000)	(2,705)	(30,000)
Sale of investments										30,000
Cash paid for business acquisition, net of cash acquired									(21,408)
Proceeds from sale of intellectual property									5,000
Cash used in investing activities								(132,214)	(91,325)	(64,409)
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:
Proceeds from revolving credit facility borrowings								1,874,000	399,600	1,909,000
Repayments of revolving credit facility borrowings								(1,874,000)	(399,600)	(1,909,000)
Repayments of long-term debt								(332,814)	(18,752)	(39,048)
Proceeds from issuance of long-term debt								350,000
Debt issuance costs								(3,263)
Net proceeds from stock issuances								2,379	2,993	7,793
Repurchases of common stock								(331,101)	(64,059)	(179,025)
Proceeds from collection of notes receivable								500	2,500
Cash used in financing activities								(314,299)	(77,318)	(210,280)
Effect of exchange rate changes								(4,510)	(199)	(81)
Increase (decrease) in cash and cash equivalents								(120,169)	169,500	25,785
Cash and cash equivalents at beginning of year	650,026		480,526	650,026	480,526	650,026	480,526	650,026	480,526	454,741
Cash and cash equivalents at end of year								529,857	650,026	480,526
Previously Reported
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income										139,713
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	27,465		27,635	55,032	54,831	82,097	82,204	108,783	109,656	114,218
Stock-based compensation expense	9,032		8,208	18,362	17,432	29,045	26,147	39,608	34,976	26,235
Deferred income taxes	6,707		3,447	11,071	13,641	18,522	32,142	31,733	33,724	13,567
Gain on sale of intellectual property									(15,000)
Gain on liquidation of foreign entity							(8,263)		(8,263)
Impairment of goodwill and other assets						1,848		1,848		8,409
Loss on sale of intellectual property								7,000
Other, net	(3,638)		(99)	(1,903)	(19)	(3,146)	(633)	1,260	(1,371)	(239)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	(106,972)		(64,217)	(79,705)	(79,166)	(39,850)	(108,277)	46,480	(146,516)	83,623
Contract assets	(15,666)		46,534	(68,545)	61,626	(110,565)	51,487	(154,933)	47,842	(283)
Inventories	(207,300)		42,282	(403,396)	75,303	(559,118)	(22,606)	(663,379)	(167,186)	39,564
Prepaid expenses and other assets	(2,939)		(9,400)	(11,334)	1,359	(13,269)	(3,574)	(31,700)	(6,486)	17,798
Accounts payable	234,525		(66,657)	357,176	(99,525)	507,632	61,524	554,492	236,270	(106,640)
Accrued liabilities	68,452		26,057	158,661	2,360	144,363	(60,963)	133,541	(48,302)	(35,410)
Cash provided by operating activities	68,300		61,811	147,273	142,900	248,956	$ 246,621	330,854	338,342	300,555
Investigative Adjustments
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income										(6,544)
Adjustments to reconcile net income to cash provided by operating activities:
Deferred income taxes	(648)	$ (5,196)	(279)	(1,898)	(4,854)	(2,529)		(3,823)	(5,349)	(1,795)
Changes in operating assets and liabilities, net of amounts acquired:
Contract assets	3,064	4,921	(15,009)	4,804	2,768	6,210		(755)	4,272	24,436
Inventories	88	15,187	15,187	4,628	15,187	6,544		19,420	17,472	(15,187)
Prepaid expenses and other assets		706	706		706				706	(706)
Accrued liabilities	$ (47)	$ 3,194	$ 68	$ (478)	$ 3,825	$ (848)		(705)	2,351	(204)
Other Adjustments
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable								1,003	706	(1,709)
Contract assets								12,157	2,365	(14,522)
Inventories								(7,159)	(7,564)
Accounts payable								4,336	7,564
Accrued liabilities								$ (8,737)	$ (3,071)	$ 16,231